| Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial ES Kim, V Hirsh, T Mok, MA Socinski, R Gervais, YL Wu, LY Li, ... The Lancet 372 (9652), 1809-1818, 2008 | 1741 | 2008 |
| A meta-analysis of thoracic radiotherapy for small-cell lung cancer JP Pignon, R Arriagada, DC Ihde, DH Johnson, MC Perry, RL Souhami, ... New England Journal of Medicine 327 (23), 1618-1624, 1992 | 1688 | 1992 |
| Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue H Pedersen, N Brünner, D Francis, K Østerlind, E Rønne, HH Hansen, ... Cancer research 54 (17), 4671-4675, 1994 | 380 | 1994 |
| Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation K Østerlind, PK Andersen Cancer research 46 (8), 4189-4194, 1986 | 261 | 1986 |
| Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma H Pedersen, J Grøndahl-Hansen, D Francis, K Østerlind, HH Hansen, ... Cancer research 54 (1), 120-123, 1994 | 230 | 1994 |
| The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the World Health Organization. A study of 375 … FR Hirsch, K Østerlind, HH Hansen Cancer 52 (11), 2144-2150, 1983 | 140 | 1983 |
| Repurposing cationic amphiphilic antihistamines for cancer treatment AM Ellegaard, C Dehlendorff, AC Vind, A Anand, L Cederkvist, ... EBioMedicine 9, 130-139, 2016 | 131 | 2016 |
| Nationwide quality improvement in lung cancer care: the role of the Danish Lung Cancer Group and Registry E Jakobsen, A Green, K Oesterlind, TR Rasmussen, M Iachina, T Palshof Journal of Thoracic Oncology 8 (10), 1238-1247, 2013 | 128 | 2013 |
| Staging and prognostic factors in small cell carcinoma of the lung. K Osterlind, DC Ihde, DS Ettinger, RJ Gralla, K Karrer, S Krauss, ... Cancer treatment reports 67 (1), 3-9, 1983 | 128 | 1983 |
| Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 … S Kubicka, R Greil, T André, J Bennouna, J Sastre, E Van Cutsem, ... Annals of oncology 24 (9), 2342-2349, 2013 | 127 | 2013 |
| Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer MK Boisen, JS Johansen, C Dehlendorff, JS Larsen, K Østerlind, ... Annals of oncology 24 (10), 2554-2559, 2013 | 116 | 2013 |
| Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up K Østerlind, HH Hansen, HS Hansen, P Dombernowsky, M Hansen, ... British journal of cancer 54 (1), 7-17, 1986 | 115 | 1986 |
| Morphologic variations of small cell lung cancer: A histopathologic study of pretreatment and posttreatment specimens in 104 patients M Sehested, FR Hirsch, K Østerlind, JE Olsen Cancer 57 (4), 804-807, 1986 | 110 | 1986 |
| Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001–2008 SO Dalton, BL Frederiksen, E Jacobsen, M Steding-Jessen, K Østerlind, ... British journal of cancer 105 (7), 1042-1048, 2011 | 109 | 2011 |
| Quality of life of elderly persons with newly diagnosed cancer BA Esbensen, K Østerlind, O Roer, IR Hallberg European journal of cancer care 13 (5), 443-453, 2004 | 105 | 2004 |
| Improved survival of colorectal cancer in Denmark during 2001–2012–the efforts of several national initiatives LH Iversen, A Green, P Ingeholm, K Østerlind, I Gögenur Acta oncologica 55 (sup2), 10-23, 2016 | 97 | 2016 |
| Data from a national lung cancer registry contributes to improve outcome and quality of surgery: Danish results E Jakobsen, T Palshof, K Østerlind, H Pilegaard European journal of cardio-thoracic surgery 35 (2), 348-352, 2009 | 91 | 2009 |
| Randomized trial of the effects of individual nutritional counseling in cancer patients GM Poulsen, LL Pedersen, K Østerlind, L Bæksgaard, JR Andersen Clinical nutrition 33 (5), 749-753, 2014 | 84 | 2014 |
| Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy M Ryberg, D Nielsen, K Østerlind, T Skovsgaard, P Dombernowsky Annals of oncology 12 (1), 81-87, 2001 | 73 | 2001 |
| Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years … U Lassen, PEG Kristjansen, K Østerlind, B Bergman, TC Sigsgaard, ... Annals of oncology 7 (4), 365-371, 1996 | 69 | 1996 |
